IMDXInsight Molecular Diagnostics Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 17033
Ticker: IMDX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-12-30
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: IMDX

Detail

Enriched 2026-08-14 20:47

Market cap: $147,259,278
Shares outstanding (class): 32,290,167
Shares outstanding (weighted): 32,724,284
SIC: 2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees: 58
Location: NASHVILLE, TN
Homepage: https://www.imdxinc.com
Description: Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Market cap and share counts drift.

Funds holding this security

5 funds · 5 positions · $1.86M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$976.7K	0.00%	297,775 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$759.2K	0.00%	231,459 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$94.6K	0.01%	28,842 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$26.0K	0.00%	7,927 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$7.6K	0.00%	2,330 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERIMDX
FIGI_COMPOSITEBBG008P5VFV1
FIGI_SHARE_CLASSBBG008P5VFW0
CIK0001642380
ISINUS68235C2061
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Medical Devices
Source: LLMunreviewed
Self-reported confidence: 0.8
Model: deepseek
Rationale: Common stock of a molecular diagnostics company, classified under healthcare medical devices.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.